01Purpose and principlesWhat the assessment is for and the core concepts behind it.
Endovascular aortic repair excludes an aneurysm from the circulation but leaves both the native sac and a modular device in place. Follow-up therefore asks three linked questions: is blood reaching the sac, is the sac shrinking or enlarging, and is the graft maintaining seal, overlap and limb patency? Absence of symptoms does not prove durable exclusion. Late migration, seal-zone dilatation, component separation, limb kinking or occult infection can convert a previously satisfactory result into rupture risk.
An endoleak is blood flow outside the endograft but within the treated aneurysm sac. Type I enters at a proximal or distal attachment site; type III crosses a component junction or fabric defect. These direct leaks expose the sac to arterial pressure and merit prompt repair. Type II enters retrogradely through branches such as lumbar or inferior mesenteric arteries and is judged with sac behavior. Type IV is flow through porous graft fabric, usually early and transient with modern devices. Type V, or endotension, describes sac enlargement without a demonstrated leak and remains a diagnosis reached only after searching for an occult source or infection.
Imaging methods answer different parts of the problem. CTA defines seal zones, overlap, migration, kinking, sac morphology and contrast filling, while delayed phases may be needed for slow type II flow. Duplex avoids radiation and iodinated contrast and measures sac size and limb flow, but is operator- and habitus-dependent. CEUS improves detection and temporal characterization of flow. Plain radiography can reveal fracture or component separation in selected device protocols but cannot assess sac perfusion. MRI can help when CTA is unsuitable and the device is compatible, although metal artefact and availability limit it.
NICE does not impose a single fixed post-EVAR schedule: enrol every patient and base frequency on complication risk. ESVS 2024 recommends early postoperative CTA within 30 days to check endoleak, overlap and seal length. A standard-EVAR patient with no endoleak, anatomy within device instructions and adequate overlap and seal may enter low-frequency imaging during the first five years, with delayed imaging around five years; high-risk anatomy or type II endoleak generally needs annual reassessment. Long-term imaging remains recommended for all risk groups. ESC advises reassessing a type II endoleak detected at one month by CT at six to twelve months; sac growth of at least 10 mm prompts consideration of embolization, while a stable or shrinking sac receives closer imaging before returning to annual follow-up. Complex repairs and every new leak, sac enlargement, compromised seal or migration need individualized shorter intervals.
Key points
- Lifelong imaging surveillance is required after EVAR or TEVAR because endoleak, migration, component failure, kinking and sac enlargement can arise late.
- Type I is an inadequate proximal or distal seal; type III is component separation or fabric failure, and both directly pressurize the sac.
- Type II is retrograde branch-vessel filling; intervene for associated aneurysm sac expansion rather than for the label alone.
- Type IV is early fabric porosity and is now rare; type V is continued sac expansion without a visible leak source after appropriate imaging.
- Suspected endoleak requires contrast-enhanced CT angiography; use contrast-enhanced ultrasound if CTA is contraindicated and never rule it out by negative colour duplex alone.
- Compare sac diameter with baseline and the smallest recorded postoperative diameter using the same modality and measurement method whenever possible.
- A sac increase of at least 10 mm is significant in ESVS guidance and triggers investigation for occult leak or infection and consideration of repair.
- After EVAR, ESVS recommends CTA within 30 days, low-frequency imaging for selected low-risk patients during five years, and long-term imaging for everyone; higher-risk repairs need closer individualized follow-up.
02Indications, selection and cautionsWhen it is useful, when urgency changes and important limitations.
Type I attachment failure or type III graft disruption creates arterial-pressure sac filling and a continuing rupture mechanism.
Type II endoleak fills retrogradely from patent aortic branches and becomes clinically important when the sac enlarges.
Progressive sac growth without visible flow suggests occult endoleak, endotension, measurement inconsistency or graft infection.
New buttock or leg claudication, rest pain, reduced pulses or acute ischaemia can follow graft limb stenosis, kinking or occlusion.
Fever, malaise, bacteraemia, back pain, perigraft gas or soft-tissue change requires urgent assessment for endograft infection.
03Method and interpretationA systematic approach to the test and its findings.
Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.
- 01
First-line programme: risk-stratified surveillance imagingFirst stepFirst line - Why
- Track sac diameter and detect EVAR-related device complications over life.
- Interpretation and limitations
- Select CTA, duplex or CEUS from initial findings, anatomy, renal function and local expertise; an apparently low-risk result reduces frequency but does not end surveillance.
- 02
Suspected endoleak: multiphase contrast-enhanced CT angiography - Why
- Localize inflow, classify leak and map seal or component failure.
- Interpretation and limitations
- Arterial and delayed enhancement patterns distinguish many direct and slow branch leaks; compare graft position, overlap and sac size with every prior study.
- 03
Contrast-enhanced ultrasound - Why
- Detect and temporally characterize sac flow without iodinated contrast.
- Interpretation and limitations
- Use when CTA is contraindicated or as a specialist surveillance tool; quality depends on operator, acoustic window and validated local expertise.
- 04
Colour duplex ultrasound - Why
- Measure aneurysm sac and assess limb patency or kinking.
- Interpretation and limitations
- A positive study can prompt CTA, but NICE says a negative colour duplex alone must not exclude a suspected endoleak.
- 05
Alternative cross-sectional or catheter imaging - Why
- Resolve unexplained sac growth or an uncertain leak classification.
- Interpretation and limitations
- Device-compatible MRI, CEUS or angiography with selective or occlusion techniques may reveal occult direct flow; also investigate infection before calling type V.
- 06
Blood tests and cultures when infection suspected - Why
- Assess inflammation, organ function and potential aortic graft infection.
- Interpretation and limitations
- Inflammatory markers are non-specific; obtain cultures before antimicrobials when safe and interpret them with CT or molecular imaging and specialist review.
04Clinical next stepsHow the result changes management or prompts escalation.
01Worked exampleInterpret enlargement after EVARFirst stepA surveillance scan reports increasing sac diameter after a previously stable infrarenal EVAR.+
- 1Retrieve the implant record, early postoperative CTA, smallest sac measurement, intervening images, renal function and current symptoms before classifying risk.
- 2Re-measure the sac using the same plane and method, then inspect proximal and distal seals, overlap, migration, limbs and arterial or delayed sac enhancement.
- 3If colour duplex is negative but concern persists, obtain CTA or CEUS rather than declaring the graft satisfactory; search for occult type I or III leak and infection.
- 4A direct leak, symptoms or rupture features prompts urgent aortic-team treatment; significant growth without a visible source requires multimodal investigation and possible relining or open conversion.
- 5Document the leak type, absolute change from baseline or postoperative nadir, action, imaging modality and next interval, then verify that the patient remains in lifelong recall.
02Direct leak pathwayRepair type I or III endoleakImaging demonstrates attachment-site leakage or endograft component or fabric failure.+
- 1Contact the treating aortic service promptly and assess symptoms, rupture signs, seal anatomy, device integrity and physiological fitness.
- 2Plan endovascular correction where feasible using extension, relining or adjunctive sealing matched to the failure mechanism.
- 3Use open conversion or graft-preserving surgery when endovascular correction is unsuitable or fails, balancing urgency against operative risk.
- 4Confirm technical exclusion and establish closer post-treatment imaging because recurrent or additional failure remains possible.
03Branch leak pathwayLink type II flow to sac behaviorRetrograde branch filling is visible after EVAR without direct attachment or device leak.+
- 1Verify classification and compare sac size consistently, because occult type I or III failure can masquerade as type II flow.
- 2Continue risk-based surveillance when the patient is asymptomatic and the sac is stable or shrinking.
- 3When the sac expands, discuss embolization or another specialist intervention after defining inflow and outflow vessels and excluding infection.
- 4Persistent growth after technically attempted embolization requires reconsideration of diagnosis and possible open conversion.
04Emergency pathwayTreat suspected rupture immediatelyPost-repair pain, collapse or shock suggests rupture or acute graft failure.+
- 1Resuscitate with senior anaesthetic and vascular input, establish large-bore access, cross-match blood and avoid delays from routine clinic processes.
- 2Perform urgent CTA when physiology allows and activate the emergency aortic repair pathway at once.
- 3If instability prevents transfer to imaging, make operative or endovascular decisions with the receiving aortic team using available bedside information.
05Risks, monitoring and follow-upComplications, safety checks and further assessment.
- Record maximal sac diameter, measurement plane, modality and comparison point so apparent growth is not created by technique changes.
- Review renal function and cumulative contrast or radiation exposure when choosing CTA, CEUS, duplex or MRI for repeated examinations.
- Track seal-zone length, neck or iliac dilatation, graft migration, component overlap, fracture, kinking and limb patency as well as endoleak.
- After any re-intervention obtain imaging that confirms the treated mechanism and continue closer follow-up until sac behavior is reassuring.
- Maintain cardiovascular secondary prevention and smoking cessation while surveillance addresses the device-specific risk.
- Use a reliable recall system and actively recover missed surveillance because late complications may remain asymptomatic until rupture.
06Special situationsVariants, exceptions and circumstances that change the usual approach.
Sac trend outranks snapshot
The direction and magnitude of sac change across comparable examinations often carries more meaning than one isolated endoleak label.
Type II can distract
When the sac grows, a visible branch leak must not prevent a deliberate search for an occult direct leak.
Type V requires exclusion
Endotension is not simply a negative CTA; alternative imaging and infection assessment may uncover a treatable cause.
Thoracic surveillance differs
TEVAR follow-up relies more heavily on cross-sectional imaging because transthoracic ultrasound cannot adequately assess the arch and descending thoracic aorta.
Measurement needs consistency
ESVS defines significant sac growth as at least ten millimetres compared with baseline or the smallest follow-up diameter using the same method.
07Common pitfallsFrequent interpretation and management errors.
- 01
Do not treat all endoleaks as equivalent; direct type I and III leaks have a different pressure and urgency profile from type II.
- 02
Do not discharge a patient from lifelong surveillance solely because the early scan is normal or the sac initially shrinks.
- 03
Do not exclude endoleak with a negative colour duplex when sac growth, symptoms or another test sustains suspicion.
- 04
Do not call unexplained expansion type V before checking measurement, occult direct leak and graft infection with appropriate additional imaging.
- 05
Do not follow only the leak: migration, seal-zone degeneration, component separation and limb occlusion are independent failure modes.
- 06
Do not expose a stable patient repeatedly to contrast without considering renal function and validated lower-risk modalities.